EN 中文
Home Strategic Partnerships News Contact us
TOTAL:36 NEWS
First Patient Enrolled for the Investigator-Initiated trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Neurotrophic Keratitis
read
2021-10-22
228
Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”
read
2021-10-16
255
Podcast Series Episode 4: Glaucoma and Zhaoke Ophthalmology's New Treatments
read
2021-10-06
431
Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”
read
2021-09-30
176
Zhaoke Ophthalmology’s IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE
read
2021-09-29
1283
>
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat